Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Dynamins represent one of the subfamilies of GTP-binding proteins. Additionally we are shipping Dynamin 2 Kits (28) and Dynamin 2 Proteins (7) and many more products for this protein.
Showing 10 out of 43 products:
Human Monoclonal DNM2 Primary Antibody for IF, IP - ABIN967865
Cook, Urrutia, McNiven: Identification of dynamin 2, an isoform ubiquitously expressed in rat tissues. in Proceedings of the National Academy of Sciences of the United States of America 1994
Show all 5 references for ABIN967865
Human Polyclonal DNM2 Primary Antibody for WB - ABIN152770
McNiven: Dynamin: a molecular motor with pinchase action. in Cell 1998
Show all 4 references for ABIN152770
Human Polyclonal DNM2 Primary Antibody for IHC - ABIN966007
Diatloff-Zito, Gordon, Duchaud, Merlin: Isolation of an ubiquitously expressed cDNA encoding human dynamin II, a member of the large GTP-binding protein family. in Gene 1995
Show all 2 references for ABIN966007
Clinical, pathological and genetic characteristics of autosomal dominant inherited dynamin 2 centronuclear myopathy.
Data demonstrate that dynamin II is required for the E2:ERalpha (show ESR1 Antibodies) signaling of physiological functions and uncovers a role for autophagy in the control of ERalpha (show ESR1 Antibodies) turnover.
This study reported the clinical characteristics, molecular diagnosis strategy, and DNM2 gene mutations of four Chinese Han patients with centronuclear myopathy.
uncover a link between the dynamin 2 function and JNK (show MAPK8 Antibodies) signaling which leads to AP-1 (show FOSB Antibodies) induction
results provide evidence for a novel Arf6 (show ARF6 Antibodies) activation mechanism by Dyn2 through EFA6B (show PSD4 Antibodies) and EFA6D (show PSD3 Antibodies) in CME in a manner dependent upon the GTPase (show RACGAP1 Antibodies) activity of Dyn2
We conclude that DNM2 is a novel negative regulator of NO production in mouse collecting ducts.
In marked contrast to invadopodia, this degradation does not require the action of Src kinase (show CSK Antibodies), Cdc42 (show CDC42 Antibodies) or Dyn2. Rather, inhibition of Dyn2 causes a marked upregulation of stromal matrix degradation
exome sequencing family study reveals that autosomal dominant spastic paraplegia linked to a GTPase (show RACGAP1 Antibodies)-effector domain mutation of dynamin 2
This study demonistrated that DNM2 mutation releated to Centronuclear myopathy.
Dynamin 2 deletion in beta cells caused glucose intolerance and reduced the 2d phase of glucose-stimulated insulin secretion. Dynamin 2 regulates insulin secretory capacity and dynamics in vivo via a mechanism depending on CME and F-actin remodeling.
Oxidative stress-induced (show SQSTM1 Antibodies) apoptosis and reactive oxygen species production are attenuated by not only Drp1 (show CRMP1 Antibodies) inhibition but also Dynamin 2 inhibition, implicating Dynamin 2 as a mediator of oxidative stress in cardiomyocytes.
Results show that centronuclear myopathy associated Dyn2 mutants are gain-of-function mutations, and their primary effect in muscle is T-tubule disorganization, which explains the susceptibility of muscle to Dyn2 hyperactivity.
Dynamin 2 might participate in the early embryonic development through an actin-based cytokinesis
Dynamin 2 has a role in endocytosis and in sustaining T-cell receptor signaling and driving metabolic reprogramming in T lymphocytes
DNM2-dependent endocytosis in megakaryocytes regulates megakaryopoiesis, thrombopoiesis, and bone marrow homeostasis.
Thus dynamin (show DNM1 Antibodies) that was recently found to control late stages of myoblast fusion also controls late stages of macrophage fusion, revealing an intriguing conserved mechanistic motif shared by diverse cell-cell fusion processes.
Using an inducible knockout mouse model to generate dynamin 1 (show DNM1 Antibodies)- and 2-deficient primary osteoclast precursors and myoblasts, it was shown that fusion of both cell types requires dynamin (show DNM1 Antibodies).
FGF21 (show FGF21 Antibodies) has a role in promoting endothelial cell angiogenesis through a dynamin-2 and Rab5 (show RAB5A Antibodies) dependent pathway
Dynamin 2 regulates spindle migration and polar body extrusion during mouse oocyte meiosis through an actin-based pathway
As low-level expression of the dynamin 3 (show DNM3 Antibodies) gene in these cells could not be excluded, we have now engineered dynamin 1 (show DNM1 Antibodies), 2 and 3 triple KO (TKO (show MRPS12 Antibodies)) fibroblasts.
Dynamin-2 directs actin polymerization at the exocytosis site where both, in concert, adjust the hormone quantal release.
role of the proline-rich domain of dynamin-2 in in vitro potentiation of endothelial nitric-oxide synthase (show NOS3 Antibodies) activity.
Knocking down dynamin-2 by small interfering RNA reduced both leukotoxin internalization and cytotoxicity.
LKT-mediated cell death involve dynamin-2 and cyclophilin D (show PPIF Antibodies)
DNM2-S619L causes disease, in part, by interfering with membrane tubulation
Our findings suggest that dnm2 and dnm2-like are orthologs to human DNM2, and that they are required for normal zebrafish development.
Dynamin 2 possibly regulates porcine oocyte maturation through its effects on actin-mediated spindle positioning and cytokinesis, and that this may depend on regulating ARP2 (show ACTR2 Antibodies) localization.
Dynamins represent one of the subfamilies of GTP-binding proteins. These proteins share considerable sequence similarity over the N-terminal portion of the molecule, which contains the GTPase domain. Dynamins are associated with microtubules. They have been implicated in cell processes such as endocytosis and cell motility, and in alterations of the membrane that accompany certain activities such as bone resorption by osteoclasts. Dynamins bind many proteins that bind actin and other cytoskeletal proteins. Dynamins can also self-assemble, a process that stimulates GTPase activity. Five alternatively spliced transcripts encoding different proteins have been described. Additional alternatively spliced transcripts may exist, but their full-length nature has not been determined.
, dynamin 2
, dynamin II